In vivo targeting of human DC-SIGN drastically enhances CD8+T-cell-mediated protective immunity

Decreased Pathology and Prolonged Survival of Human DC-SIGN Transgenic Mice during Mycobacterial Infection

(2014) M. Schaefer et al.   JOURNAL OF IMMUNOLOGY

Glycan-modified liposomes boost CD4+ and CD8+ T-cell responses by targeting DC-SIGN on dendritic cells

(2012) Wendy W.J. Unger et al.   JOURNAL OF CONTROLLED RELEASE

Expression of XCR1 Characterizes the Batf3-Dependent Lineage of Dendritic Cells Capable of Antigen Cross-Presentation

(2012) Annabell Bachem et al.   Frontiers in Immunology

Targeting DC-SIGN via its neck region leads to prolonged antigen residence in early endosomes, delayed lysosomal degradation, and cross-presentation

(2011) P. J. Tacken et al.   BLOOD

Antigen cross-presentation: extending recent laboratory findings to therapeutic intervention

(2011) T. W. H. Flinsenberg et al.   CLINICAL AND EXPERIMENTAL IMMUNOLOGY

DC-SIGN mediated antigen-targeting using glycan-modified liposomes: Formulation considerations

(2011) Medha D. Joshi et al.   INTERNATIONAL JOURNAL OF PHARMACEUTICS

Antigen Targeting to Plasmacytoid Dendritic Cells via Siglec-H Inhibits Th Cell-Dependent Autoimmunity

(2011) J. Loschko et al.   JOURNAL OF IMMUNOLOGY

Comparable T helper 1 (Th1) and CD8 T-cell immunity by targeting HIV gag p24 to CD8 dendritic cells within antibodies to Langerin, DEC205, and Clec9A

(2011) J. Idoyaga et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Exploring the vaccine potential of Dec-205 targeting in Mycobacterium tuberculosis infection in mice

(2011) Elena Stylianou et al.   VACCINE

Selective depletion of Foxp3+ Treg during sensitization phase aggravates experimental allergic airway inflammation

(2010) Abdul Mannan Baru et al.   EUROPEAN JOURNAL OF IMMUNOLOGY

Promoting tolerance to proteolipid protein-induced experimental autoimmune encephalomyelitis through targeting dendritic cells

(2010) J. N. H. Stern et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

The Human Cancer Antigen Mesothelin Is More Efficiently Presented to the Mouse Immune System when Targeted to the DEC-205/CD205 Receptor on Dendritic Cells

(2009) Bei Wang et al.   Annals of the New York Academy of Sciences

Targeting glycan modified OVA to murine DC-SIGN transgenic dendritic cells enhances MHC class I and II presentation

(2009) Satwinder Kaur Singh et al.   MOLECULAR IMMUNOLOGY

The dendritic cell subtype-restricted C-type lectin Clec9A is a target for vaccine enhancement

(2008) I. Caminschi et al.   BLOOD

CD11c provides an effective immunotarget for the generation of both CD4 and CD8 T cell responses

(2008) Fernanda V. V. Castro et al.   EUROPEAN JOURNAL OF IMMUNOLOGY